[18F]T807

T807 (AV-1451) · Avid Radiopharmaceuticals (Eli Lilly)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [18F]T807, covering 2017-03-08 to 2017-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease [Phase 1]

See pricing